デフォルト表紙
市場調査レポート
商品コード
1379062

ナノメディシン市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Nanomedicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ナノメディシン市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界のナノメディシン市場規模は、2022年に2,333億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに4,883億米ドルに達し、2022年から2028年の間に13.1%の成長率(CAGR)を示すと予測しています。

ナノメディシンとは、分子レベルで病気の治療や組織の修復に使用される、プログラム可能な特性を持つ特殊な多機能薬のことです。これは、疾患の診断、治療、予防、基礎となる病態生理学の分析のために、イメージング剤、ナノロボット、バイオチップ、ポリマー治療薬などのナノ粒子、ナノチューブ、ナノデバイスを使用することを含みます。ナノ粒子には、金属や金属酸化物、リポソーム、無機粒子などがあり、これらは薬剤の輸送や体内の到達困難な部位を標的にするために使用されます。その結果、ナノメディシンはドラッグデリバリー、画像診断、ワクチン、再生医療、インプラントなどに幅広く応用されています。

ナノメディシン市場の動向:

世界中で慢性疾患の有病率が高まっていることが、この市場に明るい見通しをもたらす主な要因の1つです。ナノメディシンは、腫瘍学、神経学、泌尿器学、感染症、眼科学、整形外科学、免疫学、心血管疾患の治療に非常に有益です。これに伴い、個別化された医薬品への嗜好の変化も市場の成長に寄与しています。さらに、診断手順を改善するためのナノスケール技術における様々な技術進歩が、他の成長促進要因として作用しています。製薬メーカーはナノロボット・システムやその他の新しいソリューションを使用して、ナノ医薬品の効果的な投与を行っています。ヘルスケアインフラの改善、バイオテクノロジー分野における広範な研究開発(R&D)活動など、その他の要因も市場の成長を促進すると予想されます。

本レポートで扱う主な質問

  • 世界のナノメディシン市場の規模は?
  • 2023-2028年の世界のナノメディシン市場の予想成長率は?
  • ナノメディシンの世界市場を牽引する主要因は何か?
  • COVID-19がナノメディシンの世界市場に与えた影響は?
  • ナノ分子タイプに基づく世界のナノメディシン市場の内訳は?
  • ナノメディシンの世界市場の製品別区分は?
  • ナノメディシンの世界市場の用途別区分は?
  • ナノメディシンの世界市場における主要地域は?
  • ナノメディシンの世界市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 ナノメディシンの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:ナノ分子タイプ別

  • ナノ粒子
    • 市場動向
    • 主要タイプ
      • 金属および金属酸化物ナノ粒子
      • リポソーム
      • ポリマーおよびポリマー薬物複合体
      • ハイドロゲル・ナノ粒子
      • デンドリマー
      • 無機ナノ粒子
    • 市場予測
  • ナノシェル
    • 市場動向
    • 市場予測
  • ナノチューブ
    • 市場動向
    • 市場予測
  • ナノデバイス
    • 市場動向
    • 市場予測

第7章 市場内訳:製品別

  • 治療薬
    • 市場動向
    • 市場予測
  • 再生医療
    • 市場動向
    • 市場予測
  • 体外診断
    • 市場動向
    • 市場予測
  • 生体内診断
    • 市場動向
    • 市場予測
  • ワクチン
    • 市場動向
    • 市場予測

第8章 市場内訳:用途別

  • がん領域
    • 市場動向
    • 市場予測
  • 感染症領域
    • 市場動向
    • 市場予測
  • 循環器内科
    • 市場動向
    • 市場予測
  • 整形外科
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Arrowhead Pharmaceuticals Inc.
    • General Electric Company
    • Luminex Corporation
    • Merck & Co. Inc.
    • Nanobiotix
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Starpharma Holdings Limited
図表

List of Figures

  • Figure 1: Global: Nanomedicine Market: Major Drivers and Challenges
  • Figure 2: Global: Nanomedicine Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Nanomedicine Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Nanomedicine Market: Breakup by Nanomolecule Type (in %), 2022
  • Figure 5: Global: Nanomedicine Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Nanomedicine Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Nanomedicine Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Nanomedicine (Nanoparticles) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Nanomedicine (Nanoparticles) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Nanomedicine (Nanoshells) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Nanomedicine (Nanoshells) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Nanomedicine (Nanotubes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Nanomedicine (Nanotubes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Nanomedicine (Nanodevices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Nanomedicine (Nanodevices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Nanomedicine (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Nanomedicine (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Nanomedicine (Regenerative Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Nanomedicine (Regenerative Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Nanomedicine (In-Vitro Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Nanomedicine (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Nanomedicine (In-Vivo Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Nanomedicine (In-Vivo Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Nanomedicine (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Nanomedicine (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Nanomedicine (Clinical Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Nanomedicine (Clinical Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Nanomedicine (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Nanomedicine (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Nanomedicine (Clinical Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Nanomedicine (Clinical Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Nanomedicine (Orthopedics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Nanomedicine (Orthopedics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Nanomedicine (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Nanomedicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Nanomedicine Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Nanomedicine Industry: SWOT Analysis
  • Figure 86: Global: Nanomedicine Industry: Value Chain Analysis
  • Figure 87: Global: Nanomedicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nanomedicine Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Nanomedicine Market Forecast: Breakup by Nanomolecule Type (in Million US$), 2023-2028
  • Table 3: Global: Nanomedicine Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Nanomedicine Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Nanomedicine Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Nanomedicine Market: Competitive Structure
  • Table 7: Global: Nanomedicine Market: Key Players
目次
Product Code: SR112023A4052

Abstract

The global nanomedicine market size reached US$ 233.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 488.3 Billion by 2028, exhibiting a growth rate (CAGR) of 13.1% during 2022-2028.

Nanomedicine refers to specialized multi-functional drugs with programmable properties used for the treatment of diseases and repairing tissues at a molecular level. It involves the use of nanoparticles, nanotubes and nanodevices, such as imaging agents, nanorobots, biochips and polymer therapeutics, for the diagnosis, treatment and prevention of a disorder and analyzing the underlying pathophysiology. The nanoparticles include metal and metal oxides, liposomes and inorganic particles, which are used for transporting the drugs and targeting difficult to reach areas in the body. As a result, nanomedicine finds extensive applications for drug delivery, diagnostic imaging, vaccines, regenerative medicines and implants.

Nanomedicine Market Trends:

The increasing prevalence of chronic medical ailments across the globe is one of the key factors creating a positive outlook for the market. Nanomedicine is highly beneficial in the treatment of oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological and cardiovascular diseases. In line with this, shifting preference for personalized medicines is also contributing to the growth of the market. Additionally, various technological advancements in the nanoscale technologies for improved diagnostic procedures are acting as other growth-inducing factors. Pharmaceutical manufacturers are using nanorobotic systems and other novel solutions for the effective administration of nanomedicines. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nanomedicine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on nanomolecule type, product and application.

Breakup by Nanomolecule Type:

Nanoparticles

Metal and Metal Oxide Nanoparticles

Liposomes

Polymers and Polymer Drug Conjugates

Hydrogel Nanoparticles

Dendrimers

Inorganic Nanoparticles

Nanoshells

Nanotubes

Nanodevices

Breakup by Product:

Therapeutics

Regenerative Medicine

In-Vitro Diagnostics

In-Vivo Diagnostics

Vaccines

Breakup by Application:

Clinical Oncology

Infectious Diseases

Clinical Cardiology

Orthopedics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA and Starpharma Holdings Limited.

Key Questions Answered in This Report

  • 1. How big is the global nanomedicine market?
  • 2. What is the expected growth rate of the global nanomedicine market during 2023-2028?
  • 3. What are the key factors driving the global nanomedicine market?
  • 4. What has been the impact of COVID-19 on the global nanomedicine market?
  • 5. What is the breakup of the global nanomedicine market based on the nanomolecule type?
  • 6. What is the breakup of the global nanomedicine market based on the product?
  • 7. What is the breakup of the global nanomedicine market based on the application?
  • 8. What are the key regions in the global nanomedicine market?
  • 9. Who are the key players/companies in the global nanomedicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nanomedicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Nanomolecule Type

  • 6.1 Nanoparticles
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Metal and Metal Oxide Nanoparticles
      • 6.1.2.2 Liposomes
      • 6.1.2.3 Polymers and Polymer Drug Conjugates
      • 6.1.2.4 Hydrogel Nanoparticles
      • 6.1.2.5 Dendrimers
      • 6.1.2.6 Inorganic Nanoparticles
    • 6.1.3 Market Forecast
  • 6.2 Nanoshells
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Nanotubes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Nanodevices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Regenerative Medicine
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 In-Vitro Diagnostics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 In-Vivo Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Vaccines
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Clinical Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Infectious Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinical Cardiology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Orthopedics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Arrowhead Pharmaceuticals Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 General Electric Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Luminex Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Merck & Co. Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Nanobiotix
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi SA
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Starpharma Holdings Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials